The Role of Immunotherapy in Pancreatic Cancer

被引：60

作者：

Mukherji, Reetu ^{[1
]}

Debnath, Dipanjan ^{[2
]}

Hartley, Marion L. ^{[1
]}

Noel, Marcus S. ^{[1
]}

机构：

[1] Medstar Georgetown Univ Hosp, Div Hematol & Oncol, Ruesch Ctr Cure Gastrointestinal Canc, Georgetown Lombardi Comprehens Canc Ctr, 3800 Reservoir Rd NW, Washington, DC 20007 USA

[2] Medstar Washington Hosp Ctr, Dept Internal Med, 110 Irving St NW, Washington, DC 20010 USA

来源：

CURRENT ONCOLOGY | 2022年 / 29卷 / 10期

关键词：

immunotherapy; PD-1; PD-L1; pancreas cancer; adenocarcinoma; checkpoint inhibitor; vaccine; COLONY-STIMULATING FACTOR; CAR T-CELLS; RAS PEPTIDE VACCINATION; SECRETING TUMOR VACCINE; RANDOMIZED PHASE-II; OPEN-LABEL; NAB-PACLITAXEL; GASTROESOPHAGEAL JUNCTION; DUCTAL ADENOCARCINOMA; CHECKPOINT BLOCKADE;

D O I：

10.3390/curroncol29100541

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pancreatic adenocarcinoma remains one of the most lethal cancers globally, with a significant need for improved therapeutic options. While the recent breakthroughs of immunotherapy through checkpoint inhibitors have dramatically changed treatment paradigms in other malignancies based on considerable survival benefits, this is not so for pancreatic cancer. Chemotherapies with modest benefits are still the cornerstone of advanced pancreatic cancer treatment. Pancreatic cancers are inherently immune-cold tumors and have been largely refractory to immunotherapies in clinical trials. Understanding and overcoming the current failures of immunotherapy through elucidating resistance mechanisms and developing novel therapeutic approaches are essential to harnessing the potential durable benefits of immune-modulating therapy in pancreatic cancer patients.

引用

页码：6864 / 6892

页数：29

共 166 条

[11] Preliminary results of a phase 1 study of sea-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) [J].

Bajor, David Lawrence ;

Gutierrez, Martin ;

Vaccaro, Gina M. ;

Masood, Ashiq ;

Brown-Glaberman, Ursa ;

Grilley-Olson, Juneko E. ;

Kindler, Hedy L. ;

Zalupski, Mark ;

Heath, Elisabeth I. ;

Piha-Paul, Sarina Anne ;

Zhou, Peigen ;

Lu, Hailing ;

Ansari, Sahar ;

Hayman, Jonathan ;

Schmitt, Michael W. ;

Coveler, Andrew L. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)

[12] Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer [J].

Balachandran, Vinod P. ;

Luksza, Marta ;

Zhao, Julia N. ;

Makarov, Vladimir ;

Moral, John Alec ;

Remark, Romain ;

Herbst, Brian ;

Askan, Gokce ;

Bhanot, Umesh ;

Senbabaoglu, Yasin ;

Wells, Daniel K. ;

Cary, Charles Ian Ormsby ;

Grbovic-Huezo, Olivera ;

Attiyeh, Marc ;

Medina, Benjamin ;

Zhang, Jennifer ;

Loo, Jennifer ;

Saglimbeni, Joseph ;

Abu-Akeel, Mohsen ;

Zappasodi, Roberta ;

Riaz, Nadeem ;

Smoragiewicz, Martin ;

Kelley, Z. Larkin ;

Basturk, Olca ;

Goenen, Mithat ;

Levine, Arnold J. ;

Allen, Peter J. ;

Fearon, Douglas T. ;

Merad, Miriam ;

Gnjatic, Sacha ;

Iacobuzio-Donahue, Christine A. ;

Wolchok, Jedd D. ;

DeMatteo, Ronald P. ;

Chan, Timothy A. ;

Greenbaum, Benjamin D. ;

Merghoub, Taha ;

Leach, Steven D. .

NATURE, 2017, 551 (7681) :512-+

[13] Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial [J].

Beatty, Gregory L. ;

O'Hara, Mark H. ;

Lacey, Simon F. ;

Torigian, Drew A. ;

Nazimuddin, Farzana ;

Chen, Fang ;

Kulikovskaya, Irina M. ;

Soulen, Michael C. ;

McGarvey, Maureen ;

Nelson, Anne Marie ;

Gladney, Whitney L. ;

Levine, Bruce L. ;

Melenhorst, J. Joseph ;

Plesa, Gabriela ;

June, Carl H. .

GASTROENTEROLOGY, 2018, 155 (01) :29-32

[14] Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies [J].

Beatty, Gregory L. ;

Haas, Andrew R. ;

Maus, Marcela V. ;

Torigian, Drew A. ;

Soulen, Michael C. ;

Plesa, Gabriela ;

Chew, Anne ;

Zhao, Yangbing ;

Levine, Bruce L. ;

Albelda, Steven M. ;

Kalos, Michael ;

June, Carl H. .

CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) :112-120

[15] Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study [J].

Bernhardt, S. L. ;

Gjertsen, M. K. ;

Trachsel, S. ;

Moller, M. ;

Eriksen, J. A. ;

Meo, M. ;

Buanes, T. ;

Gaudernack, G. .

BRITISH JOURNAL OF CANCER, 2006, 95 (11) :1474-1482

[16] BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial [J].

Bockorny, Bruno ;

Semenisty, Valerya ;

Macarulla, Teresa ;

Borazanci, Erkut ;

Wolpin, Brian M. ;

Stemmer, Salomon M. ;

Golan, Talia ;

Geva, Ravit ;

Borad, Mitesh J. ;

Pedersen, Katrina S. ;

Park, Joon Oh ;

Ramirez, Robert A. ;

Abad, David G. ;

Feliu, Jaime ;

Munoz, Andres ;

Ponz-Sarvise, Mariano ;

Peled, Amnon ;

Lustig, Tzipora M. ;

Bohana-Kashtan, Osnat ;

Shaw, Stephen M. ;

Sorani, Ella ;

Chaney, Marya ;

Kadosh, Shaul ;

Haras, Abi Vainstein ;

Von Hoff, Daniel D. ;

Hidalgo, Manuel .

NATURE MEDICINE, 2020, 26 (06) :878-+

[17] Novel patterns of response under immunotherapy [J].

Borcoman, E. ;

Kanjanapan, Y. ;

Champiat, S. ;

Kato, S. ;

Servois, V. ;

Kurzrock, R. ;

Goel, S. ;

Bedard, P. ;

Le Tourneau, C. .

ANNALS OF ONCOLOGY, 2019, 30 (03) :385-396

[18] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].

Brahmer, Julie R. ;

Tykodi, Scott S. ;

Chow, Laura Q. M. ;

Hwu, Wen-Jen ;

Topalian, Suzanne L. ;

Hwu, Patrick ;

Drake, Charles G. ;

Camacho, Luis H. ;

Kauh, John ;

Odunsi, Kunle ;

Pitot, Henry C. ;

Hamid, Omid ;

Bhatia, Shailender ;

Martins, Renato ;

Eaton, Keith ;

Chen, Shuming ;

Salay, Theresa M. ;

Alaparthy, Suresh ;

Grosso, Joseph F. ;

Korman, Alan J. ;

Parker, Susan M. ;

Agrawal, Shruti ;

Goldberg, Stacie M. ;

Pardoll, Drew M. ;

Gupta, Ashok ;

Wigginton, Jon M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465

[19] Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias [J].

Brentjens, Renier J. ;

Riviere, Isabelle ;

Park, Jae H. ;

Davila, Marco L. ;

Wang, Xiuyan ;

Stefanski, Jolanta ;

Taylor, Clare ;

Yeh, Raymond ;

Bartido, Shirley ;

Borquez-Ojeda, Oriana ;

Olszewska, Malgorzata ;

Bernal, Yvette ;

Pegram, Hollie ;

Przybylowski, Mark ;

Hollyman, Daniel ;

Usachenko, Yelena ;

Pirraglia, Domenick ;

Hosey, James ;

Santos, Elmer ;

Halton, Elizabeth ;

Maslak, Peter ;

Scheinberg, David ;

Jurcic, Joseph ;

Heaney, Mark ;

Heller, Glenn ;

Frattini, Mark ;

Sadelain, Michel .

BLOOD, 2011, 118 (18) :4817-4828

[20] Next frontiers in CAR T-cell therapy [J].

Brown, Christine E. ;

Adusumilli, Prasad S. .

MOLECULAR THERAPY-ONCOLYTICS, 2016, 3

← 1 2 3 4 5 6 7 8 9 10 →